TrialJournal of acquired immune deficiency syndromes (1999)2014

Five-year safety evaluation of maraviroc in HIV-1-infected treatment-experienced patients.

Roy M Gulick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.